Literature DB >> 16904074

Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma.

Sohya Kanata1, Masao Akagi, Shunji Nishimura, Sumio Hayakawa, Kohji Yoshida, Tatsuya Sawamura, Hiroshi Munakata, Chiaki Hamanishi.   

Abstract

It has been reported that vascular endothelial growth factor (VEGF) and its receptors play an important role in the destruction of articular cartilage in osteoarthritis through increased production of matrix metalloproteinases. We investigated whether the oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) upregulates VEGF expression in cultured bovine articular chondrocytes (BACs). Ox-LDL markedly increased VEGF mRNA expression and protein release in time- and dose-dependent manners, which was significantly suppressed by anti-LOX-1 antibody pretreatment. Activation of peroxisome proliferator-activated receptor (PPAR)-gamma was evident in BACs with ox-LDL addition and was attenuated by anti-LOX-1 antibody. The specific PPAR-gamma inhibitor GW9662 suppressed ox-LDL-induced VEGF expression. These results suggest that the ox-LDL/LOX-1 system upregulates VEGF expression in articular cartilage, at least in part, through activation of PPAR-gamma and supports the hypothesis that ox-LDL is involved in cartilage degradation via LOX-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904074     DOI: 10.1016/j.bbrc.2006.07.133

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Telomerase transduced osteoarthritis fibroblast-like synoviocytes display a distinct gene expression profile.

Authors:  Yubo Sun; David R Mauerhan; Gary S Firestein; Bryan J Loeffler; Edward N Hanley; Helen E Gruber
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

2.  Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy.

Authors:  Qianyi Lu; Li Lu; Wei Chen; Peirong Lu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-29       Impact factor: 3.117

Review 3.  Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?

Authors:  Alessandro Ottaiano; Mariachiara Santorsola; Michele Caraglia; Luisa Circelli; Valerio Gigantino; Gerardo Botti; Guglielmo Nasti
Journal:  Transl Oncol       Date:  2021-05-21       Impact factor: 4.243

Review 4.  The discovery of LOX-1, its ligands and clinical significance.

Authors:  Ryo Yoshimoto; Yoshiko Fujita; Akemi Kakino; Shin Iwamoto; Tomohide Takaya; Tatsuya Sawamura
Journal:  Cardiovasc Drugs Ther       Date:  2011-10       Impact factor: 3.727

5.  LOX-1 plays an important role in ischemia-induced angiogenesis of limbs.

Authors:  Takeru Shiraki; Takuma Aoyama; Chiharu Yokoyama; Yuka Hayakawa; Toshiki Tanaka; Kazuhiko Nishigaki; Tatsuya Sawamura; Shinya Minatoguchi
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

6.  Possible involvement of the oxLDL/LOX-1 system in the pathogenesis and progression of human intervertebral disc degeneration or herniation.

Authors:  Xinhua Li; Xuejun Wang; Zhouyang Hu; Zhaoxiong Chen; Haoxi Li; Xiaoming Liu; Zhi Yao Yong; Shanjing Wang; Zhanying Wei; Yingchao Han; Jun Tan; Cong Li; Xiao Bo He; Guixin Sun; Desheng Wu; Lijun Li
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

7.  Functional Role of PPARs in Ruminants: Potential Targets for Fine-Tuning Metabolism during Growth and Lactation.

Authors:  Massimo Bionaz; Shuowen Chen; Muhammad J Khan; Juan J Loor
Journal:  PPAR Res       Date:  2013-04-29       Impact factor: 4.964

8.  The Role of PPARs in the Endothelium: Implications for Cancer Therapy.

Authors:  David Bishop-Bailey; Karen E Swales
Journal:  PPAR Res       Date:  2008-11-24       Impact factor: 4.964

9.  Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cells.

Authors:  Iván González-Chavarría; Rita P Cerro; Natalie P Parra; Felipe A Sandoval; Felipe A Zuñiga; Valeska A Omazábal; Liliana I Lamperti; Silvana P Jiménez; Edelmira A Fernandez; Nicolas A Gutiérrez; Federico S Rodriguez; Sergio A Onate; Oliberto Sánchez; Juan C Vera; Jorge R Toledo
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

10.  Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation.

Authors:  Yun Hyi Ku; Bong-Jun Cho; Min Joo Kim; Soo Lim; Young Joo Park; Hak C Jang; Sung Hee Choi
Journal:  BMC Pharmacol Toxicol       Date:  2017-08-30       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.